I like this new video website. I need to catch up on another one. Balt, I am about to have some free time and I will read some. Thanks
glta
Our current pps does not reflect our pipeline. Just the fact that we are having these conversations is amazing.
Apaziquone and Belinostat should be able to get SPPI a fair PE. Eventually we should get back to 15 a share, this yr. I am thinking much long term though.
How about when we add Belinostat?!
Is this on the website?
Doubtful...real doubtful. Considering I find potential and do my own dd and don't listen to you guys
Company that is finally focused on 1 thing. They have suspended sales from their other products to focus on 2 things.
1) SG's Cell Encapsulation (proven with 14 patients that doubled the standard treatment
2) Chemo combo with maryjane
I doubt Crabtree will let this go down without his connections. He will have a big pharma partner with them. This is a man who has more connections than tree branches. All I have done is read PR that had input from Crabree. This is promising, Taxol was something he took care of and so will cellcap.
Jus a few thousand dollars could give you 20k at min if this works out. If it doesn't, well was it worth the risk on a penny stock? I think so. Especially with someone who was with BMS. Yes, I am holding my shares and adding on a dip Monday (probable with a huge gain the last month). If the new bottom is ten cents, well, the company is doing things. Dont take my word, look at the chart and what NVLX has personally said about the trials in Germany. Why not? thats the only question I am asking myself.
They have not always had SG...They have a whole new game plan. I love that this is the only thing they are focused on too.
whats the story behind Biomanufacturing?
As well as making the patient less sick during chemo. You and nuvilex have helped me complete my dd. I thank you.
Thank you for that notilt. More highly education conversations!
bump
explain phase1/2 show it more than doubles the best known available survival therapy for pancreatic cancer. The trials were in Germany. It shows a chart for the 1 yr survival for gemzar (18%) and NVLX Cell Encapsulation treatment (36%). There were 14 patients treated in phase 2 for capcell and 63 for gemzar's phase 3. It ACTUALLY SAYS "DOUBLE SURVIVAL RAE OVER GOLD STANDARD." THIS IS ON THEIR WESITE! IF THEY ARE LIEING, WELL, THEY WOULD ALREAY BE IN JAIL. LETS LOOK AT MANAGEMENT, THESE ARE NOT LOW LIFE #$%$. Go to the website and let it reveal to you the bashers lies.
Thanks. I just don't understand why these bashers say these studies are lies. It is in the fillings. I don't get why anyone would buy their bs. The KonLin letter is no joke. I will admit that some of the others are repetitive. But come one, Forbes!!! KonLin!
Thanks Joe
ALthough F sales are clearly different now (however 2nd half will be interesting) this is a company who now has Folotyn and about to have Belinostat. We were at 17 last year, with these new drugs and Fusilev picking back up, we should be at 15 on a low end estimate. Throw some spi 2012 and apaziquone in the mix and I am wondering why our PE can't be a 15. GIVE ME A BREAK, I am here to stay. Must I say, those 7 dollar calls would have been looking juicy right about now if you grabbed them!
There are only a few people who are not pure pumpers or horrible bashers. I am in with a cost basis of 8 cents. I plan to hold long. Have you called anyone from IR? I tried yesterday. Were you here before SG and if you were why? I am here for the long hall because of the SG subsidiary and the med mari sub. It would be nice to have intelligent convos here with real insightful people.
I've spoken with Brian quite a few times on fb. He is pretty angry with Raj. He sold all of his shares after the F sales update. He still sees opportunity, but he really does not like Raj. I told him I still have faith and will hold/add. I am glad I did.
Are you trading this at all or just holding long/adding? Anyone ever speak with their ir person? I called yesterday but no luck
What is your price target to sell? Thanks for your input